CAD Mammography Market Size Projected to Reach USD 2.70 Billion by 2035 Driven by AI Integration and Rising Breast Cancer Screening Demand

According to Precedence Research, the global CAD mammography market size was valued at USD 1.10 billion in 2025 and is projected to grow from USD 1.20 billion in 2026 to approximately USD 2.70 billion by 2035, expanding at a CAGR of 9.40% from 2026 to 2035.

With over 2.3 million new breast cancer cases reported annually worldwide, healthcare systems are rapidly adopting advanced imaging technologies such as computer-aided detection (CAD) to improve diagnostic accuracy, reduce radiologist workload, and enhance patient outcomes. The integration of artificial intelligence (AI) into mammography systems is further transforming the landscape by enabling faster, more reliable detection of abnormalities.

The Full Study is Readily Available 📥 Download Sample Pages of the Report 👉 https://www.precedenceresearch.com/sample/8341

CAD Mammography Market Size and Forecasts

🔹 Market size in 2025: USD 1.10 Billion
🔹 Market size in 2026: USD 1.20 Billion
🔹 Market size by 2035: USD 2.70 Billion
🔹 CAGR: 9.40% (2026-2035)
🔹 Forecast period: 2026-2035
🔹 Base year: 2025

How Is Artificial Intelligence Transforming CAD Mammography?

Artificial intelligence is fundamentally reshaping CAD mammography by enhancing detection precision and clinical efficiency. AI-powered CAD systems can analyze mammograms in real time, identifying suspicious lesions and patterns with high sensitivity, thereby assisting radiologists in making faster and more accurate diagnoses.

Beyond detection, AI is enabling advanced capabilities such as automated breast density assessment and personalized risk profiling. These innovations are paving the way for individualized screening strategies, improving patient outcomes while reducing unnecessary recalls and false positives.

🔗 Power Your Strategy with Full Market Data 👉 https://www.precedenceresearch.com/cad-mammography-market

CAD Mammography Market Key Growth Drivers

🔹 Rising Breast Cancer Incidence: The increasing number of breast cancer cases globally is driving demand for advanced screening technologies.

🔹 Expansion of Screening Programs: Governments and healthcare organizations are promoting early detection initiatives, increasing mammography adoption.

🔹 AI Integration in Imaging: AI-enabled CAD systems enhance diagnostic accuracy and workflow efficiency, making them highly attractive to healthcare providers.

🔹 Radiologist Shortage: Growing imaging volumes and workforce shortages are accelerating the adoption of automated diagnostic support systems.

➡️ Become a valued research partner with us https://www.precedenceresearch.com/schedule-meeting

CAD Mammography Market Opportunities

🔹 Advancements in AI and Deep Learning: Continuous innovation is improving diagnostic accuracy and expanding clinical applications.

🔹 Growing Focus on Preventive Healthcare: Increasing awareness of early detection is boosting demand for advanced screening solutions.

🔹 Emerging Markets Expansion: Rapid healthcare infrastructure development in Asia Pacific and other regions presents significant growth opportunities.

CAD Mammography Market Trends

The CAD mammography market is evolving rapidly with several transformative trends shaping its future. One of the most prominent trends is the growing adoption of AI-powered imaging systems, which significantly improve the accuracy of breast cancer detection. These systems assist radiologists by identifying suspicious lesions and offering real-time decision support, reducing diagnostic errors and delays.

Another key trend is the increasing demand for high-precision imaging and personalized screening approaches. Healthcare providers are moving toward risk-based screening strategies, where CAD systems analyze individual patient data such as breast density and medical history to deliver tailored diagnostics.

Technological advancements in deep learning algorithms are also enhancing CAD system performance, boosting clinical confidence and adoption rates. Additionally, the shift toward value-based healthcare is encouraging the use of CAD tools to optimize diagnostic outcomes while controlling costs.

🔓 Instant Access. Zero Waiting. 📥 Buy the Premium Market Research Report Now 👉 https://www.precedenceresearch.com/checkout/8341

CAD Mammography Market Regional Analysis

North America dominated the market with a 40% share in 2025, supported by strong healthcare infrastructure and high adoption of advanced imaging technologies. Widespread breast cancer awareness and regular screening programs also contribute significantly to market growth.

The U.S. leads within North America due to advanced screening systems and early adoption of AI-enabled mammography. Companies like Hologic Inc. and GE HealthCare continue to expand their CAD-based solutions, strengthening market growth.

Europe held a 30% market share in 2025, driven by government-supported screening programs and high participation rates. Countries like Germany are investing heavily in digital healthcare and advanced diagnostic technologies.

Asia Pacific accounted for a 20% share in 2025 and is expected to grow at the fastest CAGR of 10.5%. Rising breast cancer incidence, growing awareness, and expanding healthcare infrastructure are key growth drivers, especially in countries like China and India.

Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.

Try Before You Buy - Get the Sample Report@ https://www.precedenceresearch.com/sample/8341

CAD Mammography Market Segment Analysis

🔹 Type Analysis

The 3D mammography segment led the CAD mammography market with a 55% share in 2025 and is expected to maintain its dominance. Its superior imaging capability improves early cancer detection by offering clearer lesion visualization, helping radiologists better differentiate between benign and malignant tumors. This makes it the preferred choice for many healthcare providers.

The 2D mammography segment accounted for 45% of the market in 2025 and is projected to grow at a 7% CAGR from 2026 to 2035. Its affordability, simplicity, and widespread clinical use support its demand. CAD integration is also enhancing its diagnostic accuracy, while public screening programs continue to rely on it for broader accessibility.

🔹 Technology Analysis

FFDM dominated the market with a 60% share in 2025 due to its widespread use in imaging centers and hospitals. It delivers consistent image quality and integrates well with PACS and AI-based CAD systems, improving diagnostic efficiency and workflow continuity.

The analog segment held a 15% share in 2025 and is expected to grow slowly at a 3% CAGR. It remains relevant in low-resource settings due to its lower cost and continued use in decentralized healthcare facilities.

Digital Breast Tomosynthesis (DBT) accounted for a 15% share in 2025 and is projected to grow at a strong 13% CAGR. Its ability to improve early detection and reduce recall rates is driving increased adoption in preventive healthcare.

Contrast-Enhanced Mammography (CEM) held a 10% share in 2025 and is expected to grow at a 16% CAGR. It enhances detection of vascularized lesions using contrast agents, making it valuable for identifying abnormal tissue more effectively.

🔹 End-Use Analysis

Hospitals led the market with a 55% share in 2025 due to their advanced imaging infrastructure and integration of CAD systems into radiology workflows. They are also early adopters of AI-enabled technologies from major companies like GE HealthCare and Siemens Healthineers.

Diagnostic imaging centers held a 25% share in 2025 and are expected to grow at an 8% CAGR. Rising outpatient imaging demand and adoption of CAD systems to improve efficiency and accuracy are supporting this growth.

Breast cancer screening clinics accounted for a 10% share in 2025 and are expected to grow at a 9% CAGR. These clinics focus on early detection, particularly for high-risk populations, driving demand for targeted screening services.

✚ Related Topics You May Find Useful:

➡️ Mammography Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/mammography-market

➡️ Digital Mammography Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/digital-mammography-market

➡️ Mammography Systems Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/mammography-systems-market

➡️ Breast Biopsy Devices Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/breast-biopsy-devices-market

➡️ Medical X-ray Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/medical-x-ray-market

CAD Mammography Market Top Companies and Their Offerings

➢ Agfa-Gevaert Group
Agfa-Gevaert Group offers enterprise imaging platforms, PACS solutions, and CAD-compatible digital mammography workflows that enhance radiology efficiency and support AI-driven breast imaging analysis.

➢ Canon Medical Systems Corporation
Canon Medical Systems Corporation provides advanced digital mammography systems, including 3D tomosynthesis, along with AI-powered CAD tools for accurate lesion detection and breast density assessment.

➢ Carestream Health, Inc.
Carestream Health, Inc. delivers digital mammography systems, cloud-based imaging platforms, and CAD-compatible software solutions designed to improve diagnostic workflows and image management.

➢ Fujifilm Holdings Corporation
Fujifilm Holdings Corporation offers digital mammography systems such as the Amulet series, along with AI-based CAD solutions like the REiLI platform to support early breast cancer detection and workflow efficiency.

➢ GE HealthCare
GE HealthCare provides comprehensive breast imaging solutions including Senographe mammography systems, AI-enabled CAD tools, and contrast-enhanced mammography technologies for improved diagnostic accuracy.

➢ Hologic, Inc.
Hologic, Inc. specializes in women's health solutions, offering 3D mammography systems, Genius AI Detection CAD technology, and integrated breast biopsy systems for end-to-end breast cancer diagnosis.

➢ Konica Minolta, Inc.
Konica Minolta, Inc. provides digital mammography systems, AI-based diagnostic support tools, and cloud-enabled imaging solutions that enhance clinical decision-making and workflow efficiency.

➢ Leica Microsystems
Leica Microsystems offers advanced microscopy and digital pathology imaging systems that complement CAD mammography by enabling precise histopathological analysis of breast tissue.

➢ Mammotome
Mammotome delivers breast biopsy and lesion localization systems that integrate with mammography and CAD technologies to support accurate and minimally invasive breast cancer diagnosis.

➢ Medtronic plc
Medtronic plc provides image-guided surgical and minimally invasive technologies that support oncology procedures and complement CAD-based breast imaging workflows.

➢ Merge Healthcare
Merge Healthcare offers PACS, vendor-neutral archives, and AI-enabled imaging analytics platforms that facilitate CAD integration and improve interoperability in breast imaging systems.

➢ NDS Surgical Imaging
NDS Surgical Imaging provides high-resolution medical displays and visualization systems optimized for mammography and CAD image interpretation in radiology environments.

➢ Philips Healthcare
Philips Healthcare delivers digital mammography systems, AI-driven CAD tools, breast density measurement software, and integrated imaging platforms for connected and efficient breast care.

➢ Radiology Partners, Inc.
Radiology Partners, Inc. offers AI-assisted radiology interpretation services, including breast imaging and teleradiology, leveraging CAD tools to enhance diagnostic accuracy and clinical workflows.

➢ Siemens Healthineers
Siemens Healthineers provides MAMMOMAT mammography systems, AI-powered CAD software, and advanced imaging technologies such as 3D tomosynthesis and contrast-enhanced mammography for early cancer detection.

➢ Recent Advancements

⚡ In April 2026, GE HealthCare expanded its collaboration with DeepHealth to accelerate the development of AI-powered mammography solutions, showcasing innovations at the Society of Breast Imaging Annual Symposium.

⚡ In April 2026, Hologic, Inc. presented new research demonstrating the effectiveness of AI in detecting invasive breast cancers, reinforcing its importance as a diagnostic support tool.

Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.

📥 Instant Report Delivery Available | 💳 Buy Now 👉 https://www.precedenceresearch.com/checkout/8341

Segments Covered in the Report

🔸 By Type

2D Mammography
3D Mammography (Tomosynthesis)

🔸 By Technology

Full-Field Digital Mammography (FFDM)
Analog Mammography
Digital Breast Tomosynthesis (DBT)
Contrast-Enhanced Mammography (CEM)

🔸 By End-Use

Hospitals
Diagnostic Imaging Centers
Breast Cancer Screening Clinics
Others

🔸 By Region

North America
Latin America
Europe
Asia-pacific
Middle and East Africa

Connect With Us

📞 USA: +1 804 441 9344
📞 APAC: +61 485 981 310 or +91 87933 22019 | +6531051271
📞 Europe: +44 7383 092 044
📩 Email: sales@precedenceresearch.com

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

🌐 Web: https://www.precedenceresearch.com

Our Trusted Data Partners:
🔹https://www.towardshealthcare.com
🔹https://www.towardspackaging.com
🔹https://www.towardschemandmaterials.com
🔹https://www.towardsfnb.com
🔹https://www.marketstatsinsight.com

Get Recent News:
https://www.precedenceresearch.com/news

For the Latest Update, Follow Us:
🔹https://www.linkedin.com/company/precedence-research
🔹https://x.com/Precedence_R
🔹https://www.facebook.com/precedenceresearch
🔹https://precedence-research.medium.com/

This release was published on openPR.